420 Comparison of Statin Use to Non-Use on Cerebral Blood Flow Velocity in Older Adults at Risk for Alzheimers Disease: Data from a Phase II Multisite Clinical Trial

OBJECTIVES/GOALS: Reduced cerebral blood flow (CBF) along with vascular risk factors (e.g., dyslipidemia) are prevalent in Alzheimers disease (AD) and related dementias. Statins are one of the most effective pharmacologic treatments for vascular risk reduction, which may contribute to CBF in individ...

Descripción completa

Detalles Bibliográficos
Autores principales: Aaron, Stacey E., Tomoto, Tsubasa, Zhang, Rong, Billinger, Sandra A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2022
Materias:
Valued Approaches
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9209253/
http://dx.doi.org/10.1017/cts.2022.244

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9209253/
http://dx.doi.org/10.1017/cts.2022.244

Ejemplares similares